Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Autoimmune chronic spontaneous urticaria: What we know and what we do not knowKolkhir, Pavel, MD ; Church, Martin K., PhD, Dsc ; Weller, Karsten, MD ; Metz, Martin, MD ; Schmetzer, Oliver, MD ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2017-06, Vol.139 (6), p.1772-1781.e1 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticariaGericke, Janine, PhD ; Metz, Martin, MD ; Ohanyan, Tatevik, MD ; Weller, Karsten, MD ; Altrichter, Sabine, MD ; Skov, Per Stahl, MD ; Falkencrone, Sidsel, PhD ; Brand, Janko, PhD ; Kromminga, Arno, PhD ; Hawro, Tomasz, MD ; Church, Martin K., PhD, DSc ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2017-03, Vol.139 (3), p.1059-1061.e1 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapyKaplan, Allen, MD ; Ledford, Dennis, MD ; Ashby, Mark, PhD ; Canvin, Janice, MD, FRCPC ; Zazzali, James L., PhD ; Conner, Edward, MD ; Veith, Joachim, MD ; Kamath, Nikhil, MD ; Staubach, Petra, MD ; Jakob, Thilo, MD ; Stirling, Robert G., MB, FRACP ; Kuna, Piotr, MD, PhD ; Berger, William, MD ; Maurer, Marcus, MD ; Rosén, Karin, MD, PhDJournal of allergy and clinical immunology, 2013-07, Vol.132 (1), p.101-109 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria controlWeller, Karsten, MD ; Groffik, Adriane, MD ; Church, Martin K., PhD, DSc ; Hawro, Tomasz, MD ; Krause, Karoline, MD ; Metz, Martin, MD ; Martus, Peter, PhD ; Casale, Thomas B., MD ; Staubach, Petra, MD ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2014-05, Vol.133 (5), p.1365-1372.e6 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trialsZhao, Zuo-Tao, MD, PhD ; Ji, Chun-Mei, M Pharm ; Yu, Wen-Jun, MD ; Meng, Ling, M Pharm ; Hawro, Tomasz, MD ; Wei, Ji-Fu, PhD ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2016-06, Vol.137 (6), p.1742-1750.e4 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trialMetz, Martin, MD ; Schütz, Andrea, MD ; Weller, Karsten, MD ; Gorczyza, Marina, MD ; Zimmer, Sebastian, MD ; Staubach, Petra, MD ; Merk, Hans F., MD ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2017-09, Vol.140 (3), p.864-867.e5 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticariaChang, Tse Wen, PhD ; Chen, Christina, BS ; Lin, Chien-Jen, PhD ; Metz, Martin, MD ; Church, Martin K., PhD, DSc ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.337-342.e2 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Responsiveness and Minimal Important Difference of the Urticaria Control Test (UCT)Ohanyan, Tatevik, MD ; Schoepke, Nicole, MD ; Bolukbasi, Bediha, MD ; Metz, Martin, MD ; Hawro, Tomasz, MD ; Zuberbier, Torsten, MD ; Peveling-Oberhag, Adriane, MD ; Staubach, Petra, MD ; Maurer, Marcus, MD ; Weller, Karsten, MDJournal of allergy and clinical immunology, 2017-12, Vol.140 (6), p.1710-1713.e11 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1 -antihistamine–refractory chronic idiopathic urticariaSaini, Sarbjit, MD ; Rosen, Karin E., MD, PhD ; Hsieh, Hsin-Ju, PhD ; Wong, Dennis A., MD ; Conner, Edward, MD ; Kaplan, Allen, MD ; Spector, Sheldon, MD ; Maurer, Marcus, MDJournal of allergy and clinical immunology, 2011-09, Vol.128 (3), p.567-573.e1 [Periódico revisado por pares]New York, NY: ElsevierTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseMaurer, Marcus, MD ; Altrichter, Sabine, MD ; Bieber, Thomas, MD ; Biedermann, Tilo, MD ; Bräutigam, Matthias, PhD ; Seyfried, Stefan, PhD ; Brehler, Randolf, MD ; Grabbe, Jürgen, MD ; Hunzelmann, Nicolas, MD ; Jakob, Thilo, MD ; Jung, Andreas, MD ; Kleine-Tebbe, Jörg, MD ; Mempel, Martin, MD ; Meurer, Michael, MD ; Reich, Kristian, MD ; Ruëff, Franziska, MD ; Schäkel, Knut, MD ; Sengupta, Kaushik, BDS, MScD ; Sieder, Christian, MSc ; Simon, Jan C., MD ; Wedi, Bettina, MD ; Zuberbier, Torsten, MD ; Mahler, Vera, MD ; Staubach, Petra, MDJournal of allergy and clinical immunology, 2011-07, Vol.128 (1), p.202-209.e5 [Periódico revisado por pares]New York, NY: Mosby, IncTexto completo disponível |